Andrea Charles | 09/12/2011
In this podcast Sudip Kumar Majumder, Principal Scientist at Intas Biopharmaceuticals India, speaks to Andrea Charles from Pharma IQ about streamlining and redesigning the downstream process and innovations on the horizon that will change the current state of play for biopharmaceutical downstream processing. Have Your Say Rate this feature and give us your feedback in the comments section below
To continue reading this story Click Here
RECOMMENDED
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Sustainability and Inclusivity in Pharma Manufacturing: Insights from AstraZeneca’s People Hub
2024-12-11
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More